Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Immunogenicity of Seasonal Influenza Vaccine (2009/2010) in Adults and Elderly
NCT00956449Phase 2Completed
- Sponsor
- Novartis
- Start
- Jun 2009
- Primary completion
- Jul 2009
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of ARCT-2138 in influenza, sponsored by Novartis. Started Jun 2009; status: completed.
02
Drugs
ARCT-2138
03
Conditions
influenza
Beyond the preview
Go deeper on NCT00956449.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00956449.